Showing results (81-90 of 133) with videos related to
Sort By:
Pageof 14
RMD Open|November 5, 2025
Long-term safety and efficacy of upadacitinib in Japanese patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying antirheumatic drugs: 5-year results from the SELECT-SUNRISE randomised controlled trialHideto Kameda, Tsutomu Takeuchi, Kunihiro Yamaoka, et al.Breast Cancer Research and Treatment|August 8, 2018
Impact of race, ethnicity, and socioeconomic factors on receipt of radiation after breast conservation surgery: analysis of the national cancer databaseArti Parekh, Wei Fu, Chen Hu, et al.Annals of the Rheumatic Diseases|October 7, 2021
Incidence and risk factors for herpes zoster in patients with rheumatoid arthritis receiving upadacitinib: a pooled analysis of six phase III clinical trialsKevin L Winthrop, Peter Nash, Kunihiro Yamaoka, et al.RMD Open|July 26, 2024
Efficacy and safety of upadacitinib in patients with rheumatoid arthritis and inadequate response or intolerance to biological treatments: results through 5 years from the SELECT-BEYOND studyRoy Fleischmann, Sebastian Meerwein, Christina Charles-Schoeman, et al.Protein Science : a Publication of the Protein Society|April 1, 1996
Soluble monomeric acetylcholinesterase from mouse: expression, purification, and crystallization in complex with fasciculinP Marchot, R B Ravelli, M L Raves, et al.Bioorganic & Medicinal Chemistry Letters|February 3, 2007
Phenoxy thiazole derivatives as potent and selective acetyl-CoA carboxylase 2 inhibitors: Modulation of isozyme selectivity by incorporation of phenyl ring substituentsRichard F Clark, Tianyuan Zhang, Xiaojun Wang, et al.Annals of Surgical Oncology|August 2, 2012
Cost comparison of radiation treatment options after lumpectomy for breast cancerRachel A Greenup, Melissa S Camp, Alphonse G Taghian, et al.Transfusion|March 4, 2022
Hemodilution in high-risk cardiac surgery: Laboratory values, physiological parameters, and outcomesDomagoj Mladinov, Luz A Padilla, Benjamin Leahy, et al.Journal of the American Academy of Dermatology|February 5, 2025
Improvements in moderate-to-severe hidradenitis suppurativa with upadacitinib: Results from a phase 2, randomized, placebo-controlled studyLindsay S Ackerman, Bethanee J Schlosser, Tianyu Zhan, et al.HSR Proceedings in Intensive Care & Cardiovascular Anesthesia|February 27, 2013
Quality improvement in cardiac critical careK Lobdell, S Camp, S Stamou, et al.Pageof 14